A Feasibility Study of AMOR; ADHD, Mothers Online Resources
Launched by UNIVERSITY OF SOUTHERN DENMARK · Nov 6, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called AMOR, which is designed to help pregnant women and new mothers who have Attention Deficit Hyperactivity Disorder (ADHD). The goal is to see how well these women can stick to the program, how useful and satisfying they find it, and whether they experience any negative effects. The researchers also want to understand if the program can help improve symptoms of ADHD, as well as reduce stress, anxiety, and depression, and enhance overall quality of life.
To participate in this trial, women must be pregnant or new mothers with a diagnosis of ADHD, at least 18 years old, and able to read and speak Danish. They should have access to a computer and the internet. Participants will listen to 10 podcasts and attend 10 online sessions, and they will fill out questionnaires to provide feedback about their experiences. Some participants may also be invited to join an online interview to share their thoughts in more detail. This trial is currently looking for participants, and it aims to provide valuable insights into how the AMOR program can support women during pregnancy and after childbirth.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant women or new mothers with an ADHD diagnosis (WHO ICD-10; F90 or F98.8)
- • above 18 years
- • access to a computer and the internet
- • speaks and reads Danish
- Exclusion Criteria:
- • severe mental disorders, such as mental retardation, schizophrenia, psychosis or bipolar disorder
- • a score above 15 on the Generalized Anxiety Disorder assessment or a score above 18 on the Edinburg Postnatal Depression scale administered
- • current alcohol or substance abuse
About University Of Southern Denmark
The University of Southern Denmark (SDU) is a prominent research institution dedicated to advancing knowledge and innovation across various fields, including health sciences. As a clinical trial sponsor, SDU is committed to conducting rigorous and ethically sound research aimed at improving patient outcomes and informing clinical practices. Leveraging its multidisciplinary expertise and state-of-the-art facilities, SDU collaborates with healthcare professionals, industry partners, and regulatory bodies to develop and execute clinical trials that adhere to the highest standards of scientific integrity and compliance. Through its research initiatives, SDU seeks to contribute to the global body of medical knowledge and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported